4.7 Article

A Metabolomic Approach for the In Vivo Study of Gold Nanospheres and Nanostars after a Single-Dose Intravenous Administration to Wistar Rats

期刊

NANOMATERIALS
卷 9, 期 11, 页码 -

出版社

MDPI
DOI: 10.3390/nano9111606

关键词

gold nanoparticles (AuNPs); shape; biodistribution; metabolomics; toxicity; in vivo

资金

  1. European Union (FEDER) [POCI/01/0145/FEDER/007728, POCI-01-0145-FEDER-029584, POCI/01/0145/FEDER/007265]
  2. National Funds (FCT/MEC, Fundacao para a Ciencia e a Tecnologia) [PT2020 UID/MULTI/04378/2013, UID/QUI/50006/2019, UID/QUI/50006/2013]
  3. National Funds (Ministerio da Educacao e Ciencia) [PT2020 UID/MULTI/04378/2013, UID/QUI/50006/2019, UID/QUI/50006/2013]
  4. NANOMODE project [PTDC/CTM-NAN/30589/2017]
  5. national funds (FCT) [PD/BD/109634/2015, SFRH/BD/107708/2015]

向作者/读者索取更多资源

Gold nanoparticles (AuNPs) are promising nanoplatforms for drug therapy, diagnostic and imaging. However, biological comparison studies for different types of AuNPs fail in consistency due to the lack of sensitive methods to detect subtle differences in the expression of toxicity. Therefore, innovative and sensitive approaches such as metabolomics are much needed to discriminate toxicity, specially at low doses. The current work aims to compare the in vivo toxicological effects of gold nanospheres versus gold nanostars (of similar similar to 40 nm diameter and coated with 11-mercaptoundecanoic acid) 24 h after an intravenous administration of a single dose (1.33 x 10(11) AuNPs/kg) to Wistar rats. The biodistribution of both types of AuNPs was determined by graphite furnace atomic absorption spectroscopy. The metabolic effects of the AuNPs on their main target organ, the liver, were analyzed using a GC-MS-based metabolomic approach. Conventional toxicological endpoints, including the levels of ATP and reduced and oxidized glutathione, were also investigated. The results show that AuNPs preferentially accumulate in the liver and, to a lesser extent, in the spleen and lungs. In other organs (kidney, heart, brain), Au content was below the limit of quantification. Reduced glutathione levels increased for both nanospheres and nanostars in the liver, but ATP levels were unaltered. Multivariate analysis showed a good discrimination between the two types of AuNPs (sphere- versus star-shaped nanoparticles) and compared to control group. The metabolic pathways involved in the discrimination were associated with the metabolism of fatty acids, pyrimidine and purine, arachidonic acid, biotin, glycine and synthesis of amino acids. In conclusion, the biodistribution, toxicological, and metabolic profiles of gold nanospheres and gold nanostars were described. Metabolomics proved to be a very useful tool for the comparative study of different types of AuNPs and raised awareness about the pathways associated to their distinct biological effects.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据